Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Oxidative Stress in BPH

View through CrossRef
INTRODUCTION:In the present study, we investigated the relationship between potency of oxidative stress and BPH and this may assist to contribute to the realistic explanation of the ethiopathogenesis of BPH.METHODS:Seventy four newly diagnosed men with BPH (mean age: 54+/-11.2), who had not undergone any previous treatment for BPH, and 62 healthy volunteers (mean age: 55+/-14) were enrolled in the present study. To determine the antioxidative status of plasma, total antioxidant capacity (TAC) was calculated, and to determine the oxidative status of plasma (TOS) total peroxide levels were measured. The ratio of TAC to total peroxide was accepted as an indicator of oxidative stress (OSI). Data are presented as mean SD +/- unless specified. Student t-test and correlation analyses were used to evaluate the statistical significance differences in the median values recorded for all parameters between BPH and control group.RESULTS:Plasma TAC TOS were found in patients and controls (1.70 +/- 0.32, 1.68 +/- 0.19 micromol Trolox Equiv./L), (12.48 +/- 1.98, 12.40 +/- 1.14 micromol / L) respectively. OSI was calculated as 7.57 +/- 1.91, 7.48 +/- 1.33, respectively. Plasma TAC, TOS and OSI levels were not found to be significantly difference between patients and control subjects (p>0.05, p>0.05, p>0.05).CONCLUSIONS:The present study has shown that there were not relationship between potency of oxidative stress and BPH. Further well designed studies should be planned to find out whether the oxidative stress-related parameters play role in BPH as an interesting pathology in regard of the etiopathogenesis.Keywords: benign prostatic hyperplasia, oxidative stress, prostate
Title: Oxidative Stress in BPH
Description:
INTRODUCTION:In the present study, we investigated the relationship between potency of oxidative stress and BPH and this may assist to contribute to the realistic explanation of the ethiopathogenesis of BPH.
METHODS:Seventy four newly diagnosed men with BPH (mean age: 54+/-11.
2), who had not undergone any previous treatment for BPH, and 62 healthy volunteers (mean age: 55+/-14) were enrolled in the present study.
To determine the antioxidative status of plasma, total antioxidant capacity (TAC) was calculated, and to determine the oxidative status of plasma (TOS) total peroxide levels were measured.
The ratio of TAC to total peroxide was accepted as an indicator of oxidative stress (OSI).
Data are presented as mean SD +/- unless specified.
Student t-test and correlation analyses were used to evaluate the statistical significance differences in the median values recorded for all parameters between BPH and control group.
RESULTS:Plasma TAC TOS were found in patients and controls (1.
70 +/- 0.
32, 1.
68 +/- 0.
19 micromol Trolox Equiv.
/L), (12.
48 +/- 1.
98, 12.
40 +/- 1.
14 micromol / L) respectively.
OSI was calculated as 7.
57 +/- 1.
91, 7.
48 +/- 1.
33, respectively.
Plasma TAC, TOS and OSI levels were not found to be significantly difference between patients and control subjects (p>0.
05, p>0.
05, p>0.
05).
CONCLUSIONS:The present study has shown that there were not relationship between potency of oxidative stress and BPH.
Further well designed studies should be planned to find out whether the oxidative stress-related parameters play role in BPH as an interesting pathology in regard of the etiopathogenesis.
Keywords: benign prostatic hyperplasia, oxidative stress, prostate.

Related Results

Virulence of Brown Planthopper and Development of Core Collection of the Pest
Virulence of Brown Planthopper and Development of Core Collection of the Pest
Brown planthopper is the most important rice pest in Indonesia. Its high adaptability to feed and reproduce on previously introduced resistant varieties to form more virulent popul...
SUN-747 Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia
SUN-747 Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia
Abstract Introduction and Objective: Racial disparity in prostate cancer has been well established, with African American (AA) men having higher rates of diagnoses a...
ASSESSMENT OF QOL IN PATIENTS WITH LUTS DUE TO BPH AND COMPARE THE OUTCOME ON A MODIFIED BPH-QOL SCALE AND IPSS SCALE
ASSESSMENT OF QOL IN PATIENTS WITH LUTS DUE TO BPH AND COMPARE THE OUTCOME ON A MODIFIED BPH-QOL SCALE AND IPSS SCALE
Background: Lower urinary tract symptoms (LUTS) include post-micturition symptoms such as post-micturition dribble or incontinence. The present study was conducted to assess the Qo...
Oxidative stress biomarkers in dogs with benign prostatic hyperplasia
Oxidative stress biomarkers in dogs with benign prostatic hyperplasia
Abstract Background The aim of this study was to evaluate total antioxidant capacity (TAC) and biomarkers of lipid and protein peroxidation in the b...
Computer Prediction and Experimental Verification of Guizhi Fuling Pill in the Treatment of Benign Prostatic Hyperplasia
Computer Prediction and Experimental Verification of Guizhi Fuling Pill in the Treatment of Benign Prostatic Hyperplasia
Objective: Benign prostatic hyperplasia (BPH) is a prevalent condition among middle-aged and elderly males. The hypoxia-inducible factor-1α (HIF-1α) / vascular endothelial growth f...
Bidirectional Causal Relationship between Inflammatory Cytokines and Benign Prostatic Hyperplasia
Bidirectional Causal Relationship between Inflammatory Cytokines and Benign Prostatic Hyperplasia
Objective: This study aimed to establish a genetic correlation between inflammatory cytokines (IC) and benign prostatic hyperplasia (BPH) to present an empirical reference for BPH ...
Abstract 1508: Therapy resistant cancer cells containing stress granules display signatures of oxidative stress
Abstract 1508: Therapy resistant cancer cells containing stress granules display signatures of oxidative stress
Abstract Understanding and overcoming therapy resistance in cancer is crucial, as it remains a major driver of lethality. We have shown that following chemotherapy, ...

Back to Top